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Background and Objectives: Recommendations about funding 
of interventions through the full spectrum of the disease have 
often been made in isolation or been derived in separate single-
intervention analyses. We primarily evaluated and optimized 
budgetary allocations by comparing cost-effectiveness data for 
the selected preventive and management strategies throughout 
the disease course for breast cancer in HK Chinese women.
 
Methods: We developed a bio-mathematical model and 
evaluated the deployment of additional resources for breast 
cancer treatment related interventions, under the decision 
analytic rubric. Nesting a state-transition Markov model within a 
generalized cost-effectiveness analytic framework, we compared 
costs and quality-adjusted life years (QALYs) to estimate average 
cost-effectiveness ratios for the following interventions at the 
population level: biennial mass mammography (from 40 to 69 or 
79 years), reduced waiting time for post-operative radiotherapy (by 
15 or 25%), adjuvant endocrine therapy (either upfront aromatase 
inhibitor (AI) therapy or sequentially/switching with tamoxifen and 
AI use) in postmenopausal estrogen receptor positive disease, 
targeted immunotherapy in HER2 over-expressed disease, and 
enhanced palliative services (either at home or as an inpatient). 
Usual care for eligible patients in the public sector was the 
comparator.
 
Results: From strategies we considered, the optimal allocation 
of additional resources for breast cancer would sequentially be: 
a 25% reduction in waiting time for postoperative radiotherapy 
(average cost-effectiveness ratio = US$5,000 per QALY); an 
enhanced, home-based palliative care (US$7,105 per QALY); 
adjuvant, sequential endocrine therapy (US$17,963 per QALY); 
targeted immunotherapy (US$62,092 per QALY); and mass 
mammography screening of women ages 40 to 69 years 
(US$72,576 per QALY).
 
Discussion: Given the situation in Hong Kong, it appears that it 
is more cost-effective to provide women with the most intensive 
treatment and care after diagnosis of breast cancer than to offer 
young women mammography. Future research should focus 
how to deploy these decisions flexibly to fit various budgetary 
constraints, affordability of cancer medicines and ethical 
considerations.  Our results could further inform policy debates 
about resource allocation on service delivery regarding breast 
cancer diagnosis, treatments palliative care and prevention 
locally.
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Background and Aims: The causal relation between Human 
papillomavirus (HPV) and cervical cancer has enabled HPV DNA 
self-sampling to be a possible cervical screening method. This 
study investigated whether it could be an alternative approach 
by examining: 1) The uptake rate of cervical cancer screening; 
2) The acceptability and confidence of self-sampling method; 3) 
The rate of cervical intraepithelial neoplasia grade 2+ (CIN2+) in 
screening; 4) Detection between self-collected samples and Pap 
smear; 5) The costing between self-sampling and Pap smear.
Methods: All participants would adopt both screening methods, to 
minimize the sequence effect of screening methods, a crossover 
randomized controlled trial was conducted. Participants were 
allocated to 2 arms (Arm 1: self-sampling before a Pap smear, 
Arm 2: Pap smear before self-sampling). Women were also 
assessed their attitudes toward and intentions to the future use of 
HPV DNA self-sampling.
Results: A total of 392 participants were recruited. Participants 
generally accepted self-sampling as an alternative as clinician-
sampling (overall score 7.8 and 7.7 respectively), in particular, 
participants without previous experience of Pap smears preferred 
self-sampling (p<0.001). In general, participants had significantly 
more positive feelings on self-sampling with less anxious, 
less uncomfortable, more pleasant, less embarrassed, more 
relaxed, less painful, and less invasion of privacy (p < 0.001). 
However, participants trusted Pap test results more and had more 
confidence in collection than self-sampling (p < 0.001). Among 
12 abnormal Pap smear results diagnosed, only 1 was confirmed 
with CIN 1. The prevalence of HPV was 11.7 % (95% CI, 8.8 to 
15.4) with self-collected samples and 7.7% (95% CI, 5.3 to 10.9) 
with clinician-collected samples. The overall agreement between 
two screening methods was 93.9% and agreement among the 
positives was 52.0%, with a kappa of 0.65 (95% CI of 0.52-0.78). 
We estimated that the introduction of HPV DNA self-sampling 
could increase the future rate of uptake of cervical cancer 
screening by 6.5%, from 61.7% to 65.7%, and would entail lower 
costs.The difference of costs of two methods was estimated as 
HKD 645.28 per case with initial screening.
Conclusions: The high rate of detection and acceptance, and the 
lower cost of HPV DNA testing suggest it could be an alternative 
cervical screening method to overcome the barriers to Pap 
smears, and enhance the coverage of cervical cancer screening. 
Prospective study is needed to evaluate the feasibility of HPV 
self-sampling and performance in the context of population based 
screening programme.
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Introduction: Long term continuous positive airway pressure 
(CPAP) treatment has been shown to alleviate symptoms and 
prevent health-related consequences in subjects with obstructive 
sleep apnea (OSA). Poor adherence to CPAP treatment adversely 
affects the effectiveness of this therapy. CPAP education is 
important to enhance CPAP adherence. This randomized 
controlled trial (RCT) aimed to examine the efficacy of a brief 
motivational enhancement education program in improving CPAP 
adherence in OSA subjects after 1 year of CPAP treatment.
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